Press Release

CD BIOSCIENCES LAUNCHES NEW TIME-LAPSE IMAGING SERVICES FOR SCIENTISTS



CD BioSciences has recently launched its new Time-Lapse Imaging services to assist researchers in a range of fields.

FOR IMMEDIATE RELEASE

20/06/2023

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently launched its new Time-Lapse Imaging services to assist scientists in a variety of projects, including the study of cell migration in chemotaxis assays or wound healing assays, the identification of stem cells and embryos and their development, and the measurement of cell proliferation over time.

Time-lapse imaging is a powerful, versatile, and evolving imaging tool for researchers because it can capture continuous images at fixed points in time and record the dynamics of what is being observed. Time-lapse imaging of living cells can monitor the response of live cells over time and generate a wealth of image-based information to quantify the behavior of cell populations.

Time-lapse imaging has great advantages in the observation and study of cell migration because it is a high-throughput and non-invasive tool for studying cells. CD Biosciences owns advanced imaging equipment and a service support team with extensive experience in the imaging field, and can provide researchers with quality time-lapse imaging services to study cell migration, cell proliferation, etc.

CD BioSciences' new time-lapse imaging services can provide high cell viability with a good signal-to-noise ratio. The group advises clients to reduce the exposure time per image and increase the interval between cell recovery images to achieve better results. To minimize phototoxic effects, fluorophores and filters should be matched as closely as possible. Longer wavelength excitation, such as green or red rather than UV or blue, should also be used. Customers should strive to use the highest numerical aperture objective possible for optimal signal detection. Antioxidants may also be added to cell culture medium.

Scientists can now explore cellular processes in real-time and acquire insights into intricate biological systems. For example, Time-lapse imaging can be utilized to examine cell migration in chemotaxis tests or to assess wound healing. The movement of cells toward or away from a chemical gradient is known as chemotaxis. In vitro studies of wound healing are typically conducted using wound healing assays.

Embryonic and stem cell development can also be studied or identified using time-lapse imaging. Stem cells are critical to regenerative medicine because of their ability to develop into numerous cell types. Embryos go through several stages of development before becoming fully formed organisms, so it is essential to observe them with the new technology.

For more information about CD BioSciences' new time-lapse imaging services for scientific research, please visit https://www.bioimagingtech.com/time-lapse-imaging.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules. In addition, the team is capable of applying powerful analytical software to capture images of cellular structure, subcellular, or tissues to obtain useful information.

Tags:
CD BioSciences  |  Time-Lapse Imaging  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.